• Refine Query
  • Source
  • Publication year
  • to
  • Language
  • 1030
  • 752
  • 180
  • 85
  • 68
  • 57
  • 49
  • 47
  • 32
  • 27
  • 16
  • 15
  • 14
  • 8
  • 7
  • Tagged with
  • 2757
  • 834
  • 358
  • 306
  • 296
  • 260
  • 235
  • 221
  • 210
  • 209
  • 183
  • 171
  • 166
  • 165
  • 163
  • About
  • The Global ETD Search service is a free service for researchers to find electronic theses and dissertations. This service is provided by the Networked Digital Library of Theses and Dissertations.
    Our metadata is collected from universities around the world. If you manage a university/consortium/country archive and want to be added, details can be found on the NDLTD website.
311

Emitted dose estimates from Seretide® Diskus® and Symbicort® Turbuhaler® following inhalation by severe asthmatics

Assi, Khaled H., Chrystyn, Henry, Pearson, S.B., Tarsin, W. January 2006 (has links)
No / The dose emitted from dry powder inhalers may be inhalation flow-dependent. Using an ex vivo method, the Electronic Lung¿, we have measured the aerodynamic characteristics of the emitted dose for both active constituents from Seretide® Diskus® (salmeterol xinafoate 50 mcg; fluticasone propionate 500 mcg) and Symbicort® Turbuhaler® (formoterol 6 mcg; budesonide 200 mcg).1 Electronic inhalation profiles were collected from 20 severe asthmatics (mean PEFR 53% predicted) when they inhaled using a placebo Seretide® Diskus® and a placebo Symbicort® Turbuhaler®. These were replayed in the Electronic Lung¿ with the respective active inhaler in situ. Mean(S.D.) peak inhalation flow rates (PIFR) through the Diskus® and Turbuhaler® were 94.7(32.9) and 76.8(26.2) l min¿1, respectively. From the Electronic Lung¿ the Diskus® inhalation profiles provided a mean(S.D.) fine particle dose (FPD) for fluticasone propionate and salmeterol of 20.4(4.8) and 18.4(4.4)% labelled dose. For Turbuhaler® inhalation profiles the FPD was 23.1(12.9) and 20.7(11.1)% labelled dose for budesonide and formoterol, respectively. The linear (p < 0.001) relationships between FPD against PIFR for budesonide and formoterol were 3 (p = 0.002) and 2.8 (p = 0.007) times steeper than fluticasone propionate and salmeterol, respectively. The results highlight a more significant effect of inspiratory flow on variable dosage emission when using the Symbicort® Turbuhaler® compared with the Seretide® Diskus®.
312

Cellular innate immune responses to lung resection via video-assisted thoracoscopic surgery (VATS) and thoracotomy : predictors of post-operative pneumonia

Jones, Richard Oliver January 2013 (has links)
Background and Objectives: The pathophysiology of post-operative pneumonia following lung resection is poorly understood despite it being the most common complication which may lead to death. The role of the acute inflammatory response following lung resection, in particular innate immune cells, was investigated and used to identify biomarkers for post-operative pneumonia. Comparison of inflammatory responses to resection undertaken by video-assisted thorascopic surgery (VATS) and thoracotomy was also evaluated. Methods: Patients undergoing lung resection for suspected bronchogenic carcinoma were recruited. Objective pre-defined criteria were used to diagnose pneumonia. Bronchoalveolar lavage (BAL) was conducted in the contra-lateral lung pre- and postoperatively to measure cellular composition and cytokines. Blood was sampled preoperatively and 6-, 24- and 48-hours post-operatively primarily to assess neutrophil phagocytic capacity, monocyte subsets, monocyte cytokine responses to lipopolysaccharide (LPS) stimulation and serum cytokine responses. Exhaled nitric oxide (eNO) was also measured at these time points. Patient groups were compared using paired or student t-tests together with ANOVA/ANCOVA modelling. The predictive strength of the biomarkers identified was tested. Results: 40 patients were recruited. 26 patients (65%) underwent major lung resection using VATS and 14 (35%) thoracotomy. There was a post-operative blood monocytosis (p<0.0005) with an absolute expansion of classical and intermediate monocytes (p=0.001) and a relative fall in non-classical monocytes (p<0.005). Post-operatively blood monocytes became more pro-inflammatory with an overall significant increase in IL-8 (p=0.034) and TNF-α (p=0.028) together with an increase in IL-6 (p=0.028) and IL-10 by 48 hours (p=0.010). VATS was associated with a smaller release of IL-10 only (p=0.011). There was a general trend towards post-operative reduction in neutrophil phagocytosis of zymosan (in suspension) on ANOVA modelling (p=0.047). Lung resection led to an increase in serum cytokines IL-6, IL-8 and IL-10 which peaked at 24hrs before falling (p<0.0005). ANOVA modelling confirmed significantly lower levels of serum cytokines in VATS patients compared with thoracotomy (p=0.026 for IL-6, p=0.018 for IL-8 p=0.047 for IL-10). No significant post-operative change was found for IL-1β, TNF-α and IL-12p70 (p>0.05). Bronchoalveolar lavage fluid (BALF) and blood samples demonstrated a relative post-operative leucocytosis due principally to neutrophilia. A relative blood lymphopenia and thrombocytopenia developed postoperatively (p<0.0005). VATS was associated with a lower fall in serum albumin (p=0.001). BALF from the non-operated lung became more pro-inflammatory immediately post-operatively with an increase in IL-6 (p<0.0005), IL-8 (p=0.017), IL- 10 (p=0.018) and IL-1β (p=0.002). eNO tended to fall post-operatively which reached significance at 48 hrs (p=0.029). 14 patients developed pneumonia. Pre-operatively, a blood neutrophil count above 5.04x109/L had a relative risk (RR) for pneumonia of 3.3 (95% confidence interval (CI95) 1.1-10.1), and a BAL cell count of greater than 1.04x105/ml had a RR of 3.4 (CI95 1.3-9.0), whilst LPS-stimulated monocyte secretion of IL-12 of less than 0.15 pg/ml/μg protein had a RR of 3.0 (CI95 1.2-7.3). At 24 hours post-operatively, LPS-stimulated release from monocytes of IL-10 greater than 1.99 pg/ml/μg protein (RR 4.1, CI95 1.3- 12.3) and IL-6 greater than 414 pg/ml/μg protein (RR 3.1, CI95 1.2-8.1) were predictive of pneumonia. Conclusion: Lung resection is associated with significant early pro- and antiinflammatory responses. VATS resection invoked significantly lower levels of serum cytokines and albumin changes compared with thoracotomy suggesting VATS lobectomy should be the surgical treatment strategy of choice for early stage lung cancer. No difference in neutrophil function or monocyte function was however observed between the surgical groups. Clinical benefits of this reduced inflammation need to be evaluated in a larger cohort of patients. Relative pre-operative leucocytosis in blood and BAL together with monocyte hyper-responsiveness in the early postoperative period is associated with the development of pneumonia. These findings warrant further investigation for their predictive power in accurately identifying postoperative pneumonia. Ultimately, they may be incorporated into a risk stratification model enabling targeted prophylactic or earlier therapeutic intervention.
313

Gene therapy for lung cancer by adeno-associated virus-mediated expression of angiogenesis inhibitors in mouse models

Cai, Kexia., 蔡克瑕. January 2006 (has links)
published_or_final_version / abstract / Surgery / Doctoral / Doctor of Philosophy
314

Does degradation of human vault RNA3 by RNA interference reduce multidrug resistance in GLC4/REV, a small-cell lung cancer cell line?

Adam, Michael R. January 2004 (has links)
Vaults, recently discovered in 1986, are multi-subunit organelles with a molecular mass of ,--,13 MDa. The specific function of vaults is unknown, although they are believed to be involved in internal transport. These ribonucleoproteins are composed of the major vault protein, which comprises ' 70% of the vault's mass, two minor proteins, TEP1 and vPARP, and untranslated RNA(s). It is believed that the protein components of the vault are structural while the RNAs are the functional components. Implications of the vault's involvement in multi-drug resistance in cancer have been made. In some resistant cancer cells, the major vault protein and vRNA(s) are up-regulated up to 15 times when cells are exposed to a cytotoxic drug. Cytotoxic drugs such as doxorubicin are administered as a cancer treatment, but may be ineffective because the drug is actively pumped out of the cell. Multi-drug resistance is the most common failure of chemotherapeutic cancer treatment. In order to prevent the development of multi-drug resistance this research employed the use of small interfering RNA technology to down-regulate the expression of one of the vault RNAs, vRNA3, in cultured GLC4 cells, a small-cell lung cancer cell line. If the vRNA(s) are the functional portion of the vault and a cloned siRNA prevents their up-regulation after drug exposure, the cells should lose their multi-drug resistance, stimulating apoptosis. If successful, this approach may provide an alternative approach to cancer treatment in cells which respond to chemotherapy by increasing the number of vault particles.Initially, the transfection of a plasmid into GLC4 cells was optimized. The best transfection efficiency (N20%) was obtained by using GeneTherapySystems' GenePORTER2 transfection reagent in serum free conditions. To determine if the vault RNAs are the functional portion of the vault complex that confers multi-drug resistance to a cell, a small interfering RNA fragment was designed to specifically knock-down the expression of human vault RNA 3. The siRNA sequence homologous to a portion of vault RNA3 was cloned into an expression vector, and using optimized transfection protocols was transfected into GLC4/REV cells. A Western analysis using caspase-8 antibodies showed no difference in caspase-8 expression in doxorubicin treated and untreated cells. Preliminary results yielded by reverse transcriptase polymerase chain reaction amplification of isolated RNA indicated that the vRNAs were not down-regulated by the siRNAs. / Department of Biology
315

Angiogenesis in human lung tumours

Ferguson, Mary L. January 2008 (has links)
Angiogenesis, the growth of new blood vessels, is vital to tumour growth. Prevailing dogma has been that tumours cannot grow without angiogenesis. Based on this premise, anti-angiogenic drugs are used clinically. However, the principle of angiogenesis as an absolute requirement for tumour growth has been challenged with reports that many tumours are entirely or partially non-angiogenic. This study describes and quantifies characteristics of non-angiogenic non-small cell lung tumours, demonstrates non-angiogenic growth in small-cell/neuroendocrine lung tumours and investigates the underlying pathogenetic processes by comparison with angiogenic lung tumours. Hypoxia is an important stimulus for angiogenesis. Differences in response to hypoxia may determine whether a tumour produces new vessels. In order to test this, levels of. necrosis, often considered a surrogate marker of hypoxic stress, were quantified but no difference in quantity of necrosis was found Moreover, immunohistochemical investigation of hypoxia and angiogenesis factors provided no unambiguous explanation for the differences in angiogenesis. Significant differences were seen, however, in fibrosis and inflammation, which were both greater in angiogenic tumours. Differences were greater for lymphocytes rather than cells of the ‘innate’ immune system. This provided an alternative hypothesis: angiogenesis occurs during wound healing and in the growth of granulation tissue, so it is possible that tumour angiogenesis is a response to factors produced by immune cells rather than the tumour itself. A tumour’s angiogenic status may, therefore, be determined by the response it provokes from the immune system. Further work to test this theory would compare levels of immunogenic factors such as Tumour Necrosis Factor and tumour cell surface antigens such as the HLA class I molecules. The study concludes with an investigation into the molecular basis of non-angiogenic growth using the technique of comparative genomic hybridisation (CGH) which allows amplifications and deletions of areas of DNA to be calculated. High-resolution array CGH was evaluated against conventional CGH, and the results compared with previous RNA studies from our laboratory. These revealed a set of genes with consistent changes in both RNA and DNA, several of which form part of known angiogenic and inflammatory pathways.
316

Efeitos do uso da Cannabis sativa durante a gestação sobre o desenvolvimento pulmonar: estudo experimental em camundongos / Effects of Cannabis sativa during gestation on lung development: an experimental study in mice

Belotti, Luciano 19 June 2019 (has links)
A Cannabis sativa é a droga ilícita usada com maior frequência por gestantes. O Delta9-tetrahidrocanabinol é o canabinóide principal responsável pelos efeitos psicoativos agindo principalmente nos receptores canabinóides 1 no cérebro. O consumo de Cannabis durante a gestação pode afetar o sistema endocanabinóide causando impactos na fase implantacional e no desenvolvimento fetal. Além disso, o Delta9- tetrahidrocanabinol é uma substância que pode atravessar a barreira feto-placentária e estar presente no leite materno. Sabe-se, no entanto, que qualquer estímulo ou insulto em um período crítico de desenvolvimento embrionário-fetal pode representar consequências mais tarde na vida. A fumaça de Cannabis contém elementos tóxicos prejudiciais semelhantes aos da fumaça de cigarro, logo o uso crônico de Cannabis tem sido associado a efeitos deletérios sobre o sistema respiratório. Embora vários estudos abordarem os efeitos da exposição à Cannabis sativa, escassos são aqueles que estudam a exposição gestacional e seus efeitos na prole. Além disso, os efeitos da Cannabis sativa sobre o desenvolvimento pulmonar são pouco conhecidos. O objetivo deste estudo é analisar os efeitos do uso da Cannabis sativa no desenvolvimento pulmonar da prole de camundongos, cujas mães foram expostas no período de gestação e analisar os efeitos no próprio tecido pulmonar dessas mães. Camundongos fêmeas grávidas (BALB/c) com aproximadamente 3 meses foram expostas à fumaça de Cannabis sativa ou ar filtrado por um período de 13 dias. Após as exposições os pulmões e os fetos das fêmeas grávidas foram coletados e o perfil inflamatório pulmonar avaliado no lavado broncoalveolar. As análises morfologia tecidual foram conduzidas e avaliadas utilizando os parâmetros estereológicos do volume pulmonar total, volume total e densidade de volume dos compartimentos pulmonares (parênquima pulmonar, vias aéreas, vasos sanguíneos, espaços aéreos alveolares, septos alveolares, áreas de superfície total e densidade de superfície dos alvéolos). Adicionalmente foram incluídas as análises de dissector físico para a estimativa de volume médio alveolar, densidade numérica e o número total de alvéolos para as proles com 20 e 60 dias de idade. As análises estereológicas das fêmeas grávidas mostraram um aumento significativo no volume total pulmonar, no volume total dos septos e no volume total dos espaços aéreos alveolares, quando comparados com as fêmeas grávidas expostas ao ar filtrado (grupo controle). Nos fetos com 18 dias de idade gestacional, houve uma diminuição significativa no volume total pulmonar, no volume total e na densidade de volume de sacos alveolares, no volume total e na densidade de volume de mesênquima, quando comparados com o grupo controle. Na prole com 20 dias de idade, houve um aumento no volume total, na densidade de volume e de superfície das vias aéreas, quando comparados com o grupo controle. Na prole com 60 dias de idade, houve um aumento no volume total do espaço aéreo alveolar, na densidade de volume do espaço aéreo alveolar, na densidade de superfície dos septos alveolares e na estimativa do número total de alvéolos, quando comparados com o grupo controle. Já os parâmetros de densidade de volume dos septos alveolares, área de superfície total dos septos alveolares e espessura dos septos alveolares, mostraram-se diminuídas quando comparados com o grupo controle. Os resultados mostraram que a exposição à fumaça de Cannabis é capaz de induzir alterações morfológicas no tecido pulmonar de camundongos (BALB/c) fêmeas grávidas e nas suas respectivas proles / Cannabis sativa is the illicit drug most frequently used by pregnant women. Delta9-tetrahydrocannabinol is the main cannabinoid responsible for psychoactive effects and acts mainly on the cannabinoid 1 receptors in the brain. Cannabis use during pregnancy can affect the endocannabinoid system causing impacts on the implantation phase and fetal development. In addition, Delta9-tetrahydrocannabinol is a substance that can cross the fetal-placental barrier and be present in breast milk. It is known, however, that any stimulus or insult in a critical period of embryonic-fetal development can have consequences later in life. Cannabis smoke contains harmful toxic elements similar to those of cigarette smoke, so chronic use of Cannabis has been associated with deleterious effects on the respiratory system. Although several studies address the effects of exposure to Cannabis sativa, few are those who study gestational exposure and its effects on offspring. In addition, the Cannabis sativa effects on lung development are poorly understood. The aim of this study is to analyze the effects of Cannabis sativa on the mice offspring lung development whose mothers were exposed during the gestation period and to analyze the effects on the lung tissue of these mothers. Pregnant female mice (BALB / c) with approximately 3 months were exposed to Cannabis sativa smoke or filtered air for 13 days. After the exposures the lungs and fetuses of the pregnant females were collected and the lung inflammatory profile evaluated in the bronchoalveolar lavage. The tissue morphology analyzes were conducted and evaluated using the stereological parameters of total lung volume, total volume and volume density of lung compartments (lung parenchyma, airways, blood vessels, alveolar air spaces, alveolar septa, total surface areas and alveoli surface density). In addition, physical dissector analyzes were used to estimate the mean alveolar volume, numerical density and the total number of alveoli for offspring at 20 and 60 days of age. Stereological analyzes of pregnant females showed a significant increase in total lung volume, total septal volume and alveolar air spaces total volume when compared to pregnant females exposed to filtered air (control group). In fetuses with 18 days gestational age, there was a significant decrease in total lung volume, total volume and volume density of saccules, total volume and volume density of mesenchymal stroma when compared to the control group. In the 20-day-old offspring, there was an increase in total volume, volume density and surface density of airway when compared to the control group. In the 60-day-old offspring, there was an increase in total alveolar airspace volume, alveolar airspace volume density, alveolar septal surface density, and total alveolar number estimation, as compared to the control group. The alveolar septa volume density, alveolar septa total surface area and alveolar septa thickness were decreased when compared to the control group. The results showed that exposure to Cannabis smoke is able to induce morphological changes in the lung tissue of pregnant (BALB / c) mice and their respective offspring
317

Avaliação da função pulmonar por espirometria na leishmaniose visceral / Pulmonary function evaluation by spirometry in visceral leishmaniasis

Maia, Isabel Aragão 23 September 2015 (has links)
Introdução: Das formas clínicas das leishmanioses, a forma clássica da leishmaniose visceral (LV) é a forma mais grave da doença, afetando órgãos como baço, fígado e linfonodos. Como a doença apresenta um comprometimento intersticial secundário à infecção pela Leishmania, existe o envolvimento de outros órgãos. No pulmão, o envolvimento se manifesta pela pneumonite intersticial. Essa alteração foi provada por estudo anatomopatológico em hamsteres, cães e homens. Embora as pesquisas pulmonares na doença avaliem as alterações ultraestruturais provocadas pela leishmaniose, não existem estudos que avaliem o impacto dessas sobre a função pulmonar. Objetivo: Caracterizar o distúrbio ventilatório em pacientes internado com LV por espirometria. Métodos: Foram avaliados transversalmente 20 pacientes com diagnóstico confirmado por Kalazar detect, mielograma e/ou sorologia. Os parâmetros medidos foram a capacidade vital forçada (CVF), volume expiratório forçado do primeiro segundo (VEF1), índice de Tiffeneau e fluxo expiratório forçado (25-75%). Posteriormente, foram utilizados, na análise estatística, o teste não paramétrico de Mann-Whitney, teste exato de Fisher, não paramétrico de Wilcoxon e o coeficiente de correlação de Speraman. Nível de significância com p < 0,05. Resultados: A espirometria mostrou-se alterada em 14 pacientes (70%). O padrão de distúrbio ventilatório apresentado foi somente restritivo. Em relação aos dados laboratoriais, os pacientes com hipoalbuminemia apresentaram espirometria alterada. Não foi achada correlação estatisticamente significativa entre tempo de medicação, consumo de tabaco, infecção, sintomas respiratórios, ocupação, tempo de sintomas. Conclusão: Os achados da espirometria evidenciaram volumes pulmonares reduzidos, com diminuição da CVF e, em 55% dos pacientes com VEF1, também diminuído. Neste estudo, demonstrou-se que a alteração da função pulmonar está, provavelmente, relacionada à fibrose pulmonar que ocorre na LV, como descrito / The clinical forms of leishmaniasis, the classic form of visceral leishmaniasis (VL) is the most severe form of the disease, affecting organs such as the spleen, liver and lymph nodes. As the disease presents an interstitial deterioration secondary to the infection by Leishmania, there is the involvement of other organs. In the lung, the involvement is manifested by the interstitial pneumonitis. This alteration has been proved by anatomopathological studies in hamsters, dogs and men. Although the researches concerning this lung disease assess the ultrastructural alterations caused by leishmaniasis, there are no studies evaluating the impact of these on lung function. Objective: To characterize the ventilatory disorder in patients hospitalized with VL by spirometry. Methods: 20 patients were transversely evaluated with diagnosis confirmed by Kalazar Detect, myelogram and / or serology. The measured parameters were the forced vital capacity (FVC), forced expiratory volume in one second (FEV1), Tiffeneau index and forced expiratory flow (25-75%). Thereafter, the non-parametric Mann-Whitney test, Fisher\'s exact test, non-parametric Wilcoxon and Spearman correlation coefficient were used in the statistical analysis. Significance level of p < 0.05. Results: The spirometry was altered in 14 patients (70%). The presented ventilatory disorder pattern was only restrictive. Regarding the laboratory data, patients with hypoalbuminemia presented altered spirometry findings. It was not found statistically significant correlation between time of medication, smoking, infections, respiratory symptoms, occupation, time of symptoms. Conclusion: The findings of spirometry showed reduced lung volumes, with decreased FVC and in 55% of patients with FEV1 also decreased. In this study it was shown that the change in lung function is probably related to pulmonary fibrosis that occurs in the VL as described in anatomicopathological studies conducted earlier
318

Investigating factors governing cell fate decisions in respiratory epithelium

Johnson, Jo-Anne January 2018 (has links)
The maintenance of the airway/respiratory epithelium during adult homeostasis and repair and its construction during embryonic development require tightly regulated cell fate decisions. This regulation takes the form of complex transcription factor and signalling cascades, much of which are unknown, particularly in human lung development. Multiciliogenesis describes the process of specification/differentiation of airway epithelial progenitors/stem cells into mature multiciliated cells (MCCs). Here, I have identified 2 novel transcription factors, Fank1 and Jazf1 which form part of the transcription factor cascade regulating multiciliogenesis in adult and embryonic mouse tracheas. Mouse tracheal epithelium is representative of epithelium lining the entire human airway and it is possible that we will also be able to extrapolate these findings to the human airway. It is not until we fully understand the regulation of multiciliogenesis that it will be possible to look at ways of pushing basal cells towards a MCC fate for purposes of cell replacement therapy, for example in patients with mucociliary disease. As well as exploring cell fate decisions in the mouse upper airway epithelium using embryonic tracheal explants and mouse tracheal epithelial cell (MTEC) cultures, I have also explored the regulation of cell fate decisions in distal human lung epithelium at the pseudoglandular stage of development. At this stage SOX9+ distal tip cells are self-renewing and multipotent and give rise to SOX2+ stalk descendents, which differentiate into airway epithelium. The regulation of SOX9+ lung tip cell multipotency and migration of SOX2+ stalk descendents during human lung development is poorly understood. I have compared human tip (SOX9+) versus stalk (SOX2+) transcriptomes using gene ontology (GO), which has highlighted some key signalling pathways enriched in tip cells which could be important in maintaining distal tip cell multipotency. These pathways have been utilised in optimising conditions for propagating self-renewing tip-derived organoids. These organoids have the potential to be differentiated into bronchiolar and alveolar fates and as such are an invaluable research tool for studying human lung epithelial development, whilst minimising the use of human embryos and its associated ethical implications. I have also performed human tip versus mouse tip transcriptome GO analysis which highlights that although there are many similarities, there are also differences between human and mouse lung epithelium development, emphasising the need for research on human tissue.
319

Silicosis and lung cancer: a mortality study of a cohort of silicotic workers in Hong Kong. / CUHK electronic theses & dissertations collection / Digital dissertation consortium

January 2003 (has links)
Tse Lap-Ah. / "July 2003." / Thesis (Ph.D.)--Chinese University of Hong Kong, 2003. / Electronic reproduction. Hong Kong : Chinese University of Hong Kong, [2012] System requirements: Adobe Acrobat Reader. Available via World Wide Web. / Electronic reproduction. Ann Arbor, MI : ProQuest Information and Learning Company, [200-] System requirements: Adobe Acrobat Reader. Available via World Wide Web. / Mode of access: World Wide Web. / Abstracts in English and Chinese.
320

Avaliação da função pulmonar por espirometria na leishmaniose visceral / Pulmonary function evaluation by spirometry in visceral leishmaniasis

Isabel Aragão Maia 23 September 2015 (has links)
Introdução: Das formas clínicas das leishmanioses, a forma clássica da leishmaniose visceral (LV) é a forma mais grave da doença, afetando órgãos como baço, fígado e linfonodos. Como a doença apresenta um comprometimento intersticial secundário à infecção pela Leishmania, existe o envolvimento de outros órgãos. No pulmão, o envolvimento se manifesta pela pneumonite intersticial. Essa alteração foi provada por estudo anatomopatológico em hamsteres, cães e homens. Embora as pesquisas pulmonares na doença avaliem as alterações ultraestruturais provocadas pela leishmaniose, não existem estudos que avaliem o impacto dessas sobre a função pulmonar. Objetivo: Caracterizar o distúrbio ventilatório em pacientes internado com LV por espirometria. Métodos: Foram avaliados transversalmente 20 pacientes com diagnóstico confirmado por Kalazar detect, mielograma e/ou sorologia. Os parâmetros medidos foram a capacidade vital forçada (CVF), volume expiratório forçado do primeiro segundo (VEF1), índice de Tiffeneau e fluxo expiratório forçado (25-75%). Posteriormente, foram utilizados, na análise estatística, o teste não paramétrico de Mann-Whitney, teste exato de Fisher, não paramétrico de Wilcoxon e o coeficiente de correlação de Speraman. Nível de significância com p < 0,05. Resultados: A espirometria mostrou-se alterada em 14 pacientes (70%). O padrão de distúrbio ventilatório apresentado foi somente restritivo. Em relação aos dados laboratoriais, os pacientes com hipoalbuminemia apresentaram espirometria alterada. Não foi achada correlação estatisticamente significativa entre tempo de medicação, consumo de tabaco, infecção, sintomas respiratórios, ocupação, tempo de sintomas. Conclusão: Os achados da espirometria evidenciaram volumes pulmonares reduzidos, com diminuição da CVF e, em 55% dos pacientes com VEF1, também diminuído. Neste estudo, demonstrou-se que a alteração da função pulmonar está, provavelmente, relacionada à fibrose pulmonar que ocorre na LV, como descrito / The clinical forms of leishmaniasis, the classic form of visceral leishmaniasis (VL) is the most severe form of the disease, affecting organs such as the spleen, liver and lymph nodes. As the disease presents an interstitial deterioration secondary to the infection by Leishmania, there is the involvement of other organs. In the lung, the involvement is manifested by the interstitial pneumonitis. This alteration has been proved by anatomopathological studies in hamsters, dogs and men. Although the researches concerning this lung disease assess the ultrastructural alterations caused by leishmaniasis, there are no studies evaluating the impact of these on lung function. Objective: To characterize the ventilatory disorder in patients hospitalized with VL by spirometry. Methods: 20 patients were transversely evaluated with diagnosis confirmed by Kalazar Detect, myelogram and / or serology. The measured parameters were the forced vital capacity (FVC), forced expiratory volume in one second (FEV1), Tiffeneau index and forced expiratory flow (25-75%). Thereafter, the non-parametric Mann-Whitney test, Fisher\'s exact test, non-parametric Wilcoxon and Spearman correlation coefficient were used in the statistical analysis. Significance level of p < 0.05. Results: The spirometry was altered in 14 patients (70%). The presented ventilatory disorder pattern was only restrictive. Regarding the laboratory data, patients with hypoalbuminemia presented altered spirometry findings. It was not found statistically significant correlation between time of medication, smoking, infections, respiratory symptoms, occupation, time of symptoms. Conclusion: The findings of spirometry showed reduced lung volumes, with decreased FVC and in 55% of patients with FEV1 also decreased. In this study it was shown that the change in lung function is probably related to pulmonary fibrosis that occurs in the VL as described in anatomicopathological studies conducted earlier

Page generated in 0.0548 seconds